Skip Navigation

Receive this page by email each issue: [Sign up for eTOCs]

Contents: Volume 27, Supplement C, 1991   [Index by Author] 


Down Other Departments
Down Articles


[Search ALL Issues]

Front Matter (PDF)

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

Other Departments Back

Peter Davey, Roger Finch, and Martin Wood
Preface
J. Antimicrob. Chemother. 1991 27: iii; doi:10.1093/jac/27.suppl_C.iii [PDF] [Request Permissions]  

Articles Back

J. J. Muscato, D. W. Wilbur, J. J. Stout, and R. A. Fahrlender
An evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage
J. Antimicrob. Chemother. 1991 27: 1-7; doi:10.1093/jac/27.suppl_C.1 [Abstract] [PDF] [Request Permissions]  

Barbro Isaksson, Håkan Hanberger, Rolf Maller, Lennart E. Nilsson, and Maud Nilsson
Synergistic post-antibiotic effect of amikacin and β-lactam antibiotics on Enterococcus faecalis
J. Antimicrob. Chemother. 1991 27: 9-14; doi:10.1093/jac/27.suppl_C.9 [Abstract] [PDF] [Request Permissions]  

Michael N. Dudley and Stephen H. Zinner
Single daily dosing of amikacin in an in-vitro model
J. Antimicrob. Chemother. 1991 27: 15-19; doi:10.1093/jac/27.suppl_C.15 [Abstract] [PDF] [Request Permissions]  

Jürg Blaser
Efficacy of once- and thrice-daily dosing of aminoglycosides in in-vitro models of infection
J. Antimicrob. Chemother. 1991 27: 21-28; doi:10.1093/jac/27.suppl_C.21 [Abstract] [PDF] [Request Permissions]  

William A. Craig, Jay Redington, and Steven C. Ebert
Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections
J. Antimicrob. Chemother. 1991 27: 29-40; doi:10.1093/jac/27.suppl_C.29 [Abstract] [PDF] [Request Permissions]  

Marc E. De Broe, Ludo Verbist, and Gert A. Verpooten
Influence of dosage schedule on renal cortical accumulation of amikacin and tobramycin in man
J. Antimicrob. Chemother. 1991 27: 41-47; doi:10.1093/jac/27.suppl_C.41 [Abstract] [PDF] [Request Permissions]  

Paul M. Tulkens
Pharmacokinetic and toxicological evaluation of a once-daily regimen versus conventional schedules of netilmicin and amikacin
J. Antimicrob. Chemother. 1991 27: 49-61; doi:10.1093/jac/27.suppl_C.49 [Abstract] [PDF] [Request Permissions]  

P. Van Der Auwera
Pharmacokinetic evaluation of single daily dose amikacin
J. Antimicrob. Chemother. 1991 27: 63-71; doi:10.1093/jac/27.suppl_C.63 [Abstract] [PDF] [Request Permissions]  

H. Giamarellou, K. Yiallouros, G. Petrikkos, E. Moschovakis, E. Vavouraki, D. Voutsinas, and P. Sfikakis
Comparative kinetics and efficacy of amikacin administered once or twice daily in the treatment of systemic Gram-negative infections
J. Antimicrob. Chemother. 1991 27: 73-79; doi:10.1093/jac/27.suppl_C.73 [Abstract] [PDF] [Request Permissions]  

P. E. Marik, I. Havlik, F. S. E. Monteagudo, and J. Lipman
The pharmacokinetics of amikacin in critically ill adult and paediatric patients: comparison of once- versus twice-daily dosing regimens
J. Antimicrob. Chemother. 1991 27: 81-89; doi:10.1093/jac/27.suppl_C.81 [Abstract] [PDF] [Request Permissions]  

Gilles Beaucaire, Olivier Leroy, Claude Beuscart, Patrick Karp, Christian Chidiac, Michéle Caillaux, and the Study Group
Clinical and bacteriological efficacy, and practical aspects of amikacin given once daily for severe infections
J. Antimicrob. Chemother. 1991 27: 91-103; doi:10.1093/jac/27.suppl_C.91 [Abstract] [PDF] [Request Permissions]  

D. A. Kafetzis, L. Sianidou, E. Vlachos, J. Davros, T. Baïramis, Y. Papandreou, E. Paraskaki, M. Scouroliakou, A. Hadzis, and J. Papadatos
Clinical and pharmacokinetic study of a single daily dose of amikacin in paediatric patients with severe Gram-negative infections
J. Antimicrob. Chemother. 1991 27: 105-112; doi:10.1093/jac/27.suppl_C.105 [Abstract] [PDF] [Request Permissions]  

C. Viscoli, M. Dudley, G. Ferrea, L. Boni, E. Castagnola, M. A. Barretta, E. Lanino, A. Loy, C. Moroni, M. Somenzi, M. Stura, and L. Pozzo
Serum concentrations and safety of single daily dosing of amikacin in children undergoing bone marrow transplantation
J. Antimicrob. Chemother. 1991 27: 113-120; doi:10.1093/jac/27.suppl_C.113 [Abstract] [PDF] [Request Permissions]  

R. Maller, H. Ahrne, T. Eilard, I. Eriksson, I. Lausen, and the Scandinavian Amikacin Once Daily Study Group
Efficacy and safety of amikacin in systemic infections when given as a single daily dose or in two divided doses
J. Antimicrob. Chemother. 1991 27: 121-128; doi:10.1093/jac/27.suppl_C.121 [Abstract] [PDF] [Request Permissions]  

F. Meunier, P. Van der Auwera, M. Aoun, S. Ibrahim, and P. M. Tulkens
Empirical antimicrobial therapy with a single daily dose of ceftriaxone plus amikacin in febrile granulocytopenic patients: a pilot study
J. Antimicrob. Chemother. 1991 27: 129-139; doi:10.1093/jac/27.suppl_C.129 [Abstract] [PDF] [Request Permissions]  

Hugo Trujillo, Jaime Robledo, Carlos Robledo, David Espinal, Gloria Garces, Jorje Mejia, Carlos Restrepo, Felipe Restrepo, Gloria Isabel Mejia de Rodriguez, and Marta Claudia Tamayo de Guitierrez
Single daily dose amikacin in paediatric patients with severe Gram-negative infections
J. Antimicrob. Chemother. 1991 27: 141-147; doi:10.1093/jac/27.suppl_C.141 [Abstract] [PDF] [Request Permissions]  

J.-C. Pechére, W. A. Craig, and F. Meunier
Once daily dosing of aminoglycoside: one step forward
J. Antimicrob. Chemother. 1991 27: 149-152; doi:10.1093/jac/27.suppl_C.149 [PDF] [Request Permissions]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.